We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
-6.53%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$2.22B
AUM Growth
-$183M
Cap. Flow
+$232M
Cap. Flow %
10.46%
Top 10 Hldgs %
43.38%
Holding
539
New
107
Increased
241
Reduced
129
Closed
35

Sector Composition

Rank Sector Weight
1 Healthcare 31.55%
2 Technology 11.24%
3 Financials 4.91%
4 Energy 4.8%
5 Consumer Discretionary 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
301
Xylem
XYL
$28.1B
$549K 0.02%
3,978
+58
+1% +$7.89K
CFR icon
302
Cullen/Frost Bankers
CFR
$10.2B
$539K 0.02%
4,787
-90
-2% -$9.43K
IWS icon
303
iShares Russell Mid-Cap Value ETF
IWS
$16B
$530K 0.02%
4,216
-89
-2% -$10.8K
PFF icon
304
iShares Preferred and Income Securities ETF
PFF
$13.3B
$527K 0.02%
16,521
IGV icon
305
iShares Expanded Tech-Software Sector ETF
IGV
$14.5B
$523K 0.02%
6,147
-62
-1% -$5.09K
RFI
306
Cohen & Steers Total Return Realty Fund
RFI
$310M
$509K 0.02%
42,499
JMST icon
307
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.1B
$508K 0.02%
10,000
MEDP icon
308
Medpace
MEDP
$16.5B
$496K 0.02%
+1,170
New +$463K
PFE icon
309
Pfizer
PFE
$153B
$493K 0.02%
16,609
+5,104
+44% +$141K
ADM icon
310
Archer Daniels Midland
ADM
$36.9B
$490K 0.02%
7,560
+1,799
+31% +$110K
RL icon
311
Ralph Lauren
RL
$23.6B
$486K 0.02%
2,897
+1,661
+134% +$287K
ALNY icon
312
Alnylam Pharmaceuticals
ALNY
$29.3B
$486K 0.02%
+2,052
New +$324K
FNCL icon
313
Fidelity MSCI Financials Index ETF
FNCL
$2.4B
$484K 0.02%
7,898
-72
-0.9% -$4.17K
RHI icon
314
Robert Half
RHI
$4.37B
$483K 0.02%
+7,248
New +$497K
SNX icon
315
TD Synnex
SNX
$20.2B
$483K 0.02%
4,119
+1,156
+39% +$141K
FMC icon
316
FMC
FMC
$1.33B
$478K 0.02%
+7,973
New +$477K
BND icon
317
Vanguard Total Bond Market
BND
$158B
$475K 0.02%
6,516
+8
+0.1% +$573
ADI icon
318
Analog Devices
ADI
$190B
$472K 0.02%
1,975
+216
+12% +$46.1K
MTCH icon
319
Match Group
MTCH
$8.55B
$472K 0.02%
13,476
+1,010
+8% +$31.9K
IWM icon
320
iShares Russell 2000 ETF
IWM
$83B
$468K 0.02%
2,146
-122
-5% -$24.7K
VB icon
321
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$465K 0.02%
2,040
+303
+17% +$66.5K
EFAV icon
322
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.51B
$464K 0.02%
6,479
EVRG icon
323
Evergy
EVRG
$19.2B
$463K 0.02%
+8,400
New +$447K
WING icon
324
Wingstop
WING
$3.18B
$461K 0.02%
1,259
+669
+113% +$257K
PAYX icon
325
Paychex
PAYX
$42.7B
$457K 0.02%
3,676
-144
-4% -$17.6K

Similar funds

Pallas Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Pallas Capital Advisors held 539 positions worth $2.22B, down 7.6% from $2.4B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pallas Capital Advisors deployed $232M of net new capital in Q2 2024, opening 107 new positions and adding to 241 existing holdings. Its largest new stake was Fidelity International Value Factor ETF: 633,680 shares worth $16.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 41% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard FTSE All-World ex-US Small-Cap Index Fund, an estimated $13.5M trimmed.

  • Pallas Capital Advisors's largest Q2 2024 buy was Fidelity International Value Factor ETF: 633,680 shares worth $16.5M.
  • Pallas Capital Advisors added most to Broadcom in Q2 2024, an estimated $166M increase.
  • Pallas Capital Advisors's biggest Q2 2024 reduction was Vanguard FTSE All-World ex-US Small-Cap Index Fund, cutting an estimated $13.5M.
  • Pallas Capital Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $9.23M.
  • Pallas Capital Advisors's ten largest holdings make up 43% of its $2.22B portfolio in Q2 2024.
  • Pallas Capital Advisors opened 107 new positions and closed 35 in Q2 2024.
  • Pallas Capital Advisors's portfolio value fell 7.6% quarter-over-quarter to $2.22B.

Based on Pallas Capital Advisors's 13F filing for Q2 2024, filed 22 Jul 2024.